Diebold (DBD - Get Report) was upgraded to overweight from neutral at J.P. Morgan. $33 price target. The stock is down 13% over the past month and has potential catalysts on the horizon, J.P. Morgan said.
Imperva (IMPV) was downgraded to neutral from buy at Nomura. $50 price target. The stock is already factoring in takeover potential, Nomura said.
Oshkosh was upgraded to overweight from neutral at J.P. Morgan. This was a valuation call, based on a $60 price target, J.P. Morgan said.
Charles Schwab (SCHW - Get Report) was initiated with an overweight rating at Morgan Stanley. $37 price target. The company is a market leader and should average 18% earnings growth over the next two years, Morgan Stanley said.